Press "Enter" to skip to content

Risks Associated with Use of Rupture of Membranes Tests – Letter to Health Care Providers

The FDA is reminding health care providers that tests to detect rupture of the amniotic membranes should not be used without other clinical assessments to make critical patient management decisions.

Original source: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm616220.htm

Also Read:   Coronavirus (COVID-19) Update: Daily Roundup October 2, 2020

Be First to Comment

Leave a Reply

Your email address will not be published.